Shock induction by arterial hypoperfusion of the gut involves synergistic interactions between the peripheral enkephalin and nitric oxide systems

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 1, 2005, Pages 33-48

  Carmignani, Marco ^a   Zucchetti, F ^b   Sacco, R ^c   Bolognini, S ^c   Volpe, A R ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Delta opioid receptors; Enkephalins; Inducible nitric oxide synthase; Nitric oxide; Splanchnic artery hypoperfusion shock

Indexed keywords

1,3 THIAZINE DERIVATIVE; 2 AMINO 5,6 DIHYDRO 6 METHYL 4H 1,3 THIAZINE; ACETYLCHOLINE; ADENOSINE; ADRENALIN; ANGIOTENSIN; BINALTORPHIMINE; BRADYKININ; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; ENKEPHALIN; FENOPROFEN; HISTAMINE; HYDROCORTISONE; INDUCIBLE NITRIC OXIDE SYNTHASE; LEUCINE ENKEPHALIN; METENKEPHALIN; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONE; NALTRINDOLE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; NORBINALTORPHIMINE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; HEART RATE; HEMODYNAMIC PARAMETERS; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; METABOLIC PARAMETERS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SHOCK; SPLANCHNIC BLOOD FLOW; SUPERIOR MESENTERIC ARTERY;

EID: 14844283709     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800105     Document Type: Article

References (60)

1. Parrillo J.E. 1993. Pathogenetic mechanisms of septic shock. New Engl. J. Med. 328:953.
2. Cuzzocrea S., D.P. Riley, A.P. Caputi and D. Salvemini. 2001. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53:135.
3. Takakura K., T. Taniguchi, I. Muramatsu, K. Takeuchi and S. Fukuda. 2002. Modification of alpha 1-adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit. Care Med. 30:894.
4. Feuerstein G. and J.M. Hallenback. 1987. Prostaglandins, leukotrienes and platelet-activating factor in shock. Ann. Rev. Pharmacol. Toxicol. 27:301.
5. Jarrar D., H.I. Chaudry and P. Wang. 1999. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches. Int. J. Mol. Med. 4:575.
6. Cobb J.P. 1999. Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red. Crit. Care Med. 27:855.
7. Schoonover L.L., A.S. Stewart and G.D. Clifton. 2000. Hemodynamic and cardiovascular effects of nitric oxide modulation in the therapy of septic shock. Pharmacotherapy 2:1184.
8. Vincent J.L., H. Zhang, C. Szabo and J.C. Preiser. 2000. Effects of nitric oxide in septic shock. Am. J. Respir. Crit. Care Med. 161:1781.
9. Lefer A.M. 1987. Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock. Am. J. Physiol. 252:R193.
10. Lock G. and J. Scholmerich. 1995. Non-occlusive mesenteric ischemia. Hepato-Gastroenterology 42:234.
11. Mitsuoka H., E.B. Kistler and G.W. Schmid-Schonbein. 2000. Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes. Proc. Natl. Acad. Sci. USA 97:772.
12. Hassoun H.T., B.C. Kone, D.W. Mercer, F.G. Moody, N.W. Weisbrodt and F.A. Moore. 2001. Post-injury multiple organ failure: the role of the gut. Shock 15:10.
13. Ackland G., M.P. Grocott and M.G. Mythen. 2000. Understanding gastrointestinal perfusion in critical care: so near, and yet so far. Crit. Care 4:269.
14. Reilly P.H., K.B. Wilkins, K.C. Fuh, U. Haglund and G.B. Bulkley. 2001. The mesenteric hemodynamic response to circulatory shock: an overview. Shock 15:329.
15. Cuzzocrea S., B. Zingarelli and A.P. Caputi. 1998. Role of constitutive nitric oxide synthase and peroxynitrite production in a rat model of splanchnic artery occlusion shock. Life Sci. 63:789.
16. Kramer W. 1988. Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. Pharmacol. Rev. 40:121.
17. Aneman A., S. Medbak, D. Watson and E. Haglind. 1994. Changes in circulating plasma met-enkephalin concentration in feline intestinal ischemia-reperfusion. Res. Exp. Med. 19:129.
18. Carmignani M. and A.R. Volpe. 1996. Nitric oxide and δ-opioid receptors in the tissue interactions among enkephalins, angiotensins and kinins. Immunopharmacology 32:172.
19. Volpe A.R., B. Giardina, P. Preziosi and M. Carmignani. 1996. Biosynthesis of endothelium-derived nitric oxide by bradykinin as endogenous precursor. Immunopharmacology 33:287.
20. Wilderman M.J. and W.M. Armstead. 1996. Relationship between nitric oxide and opioids in hypoxia-induced pial artery vasodilation. Am. J. Physiol. 270:H869.
21. Volpe A.R., G. Fontecchio and M. Carmignani. 1999. Regulatory role of bradykinin in the coronaric and cerebral circulations and in systemic hemodynamics. Immunopharmacology 44:87.
22. Holaday J.W. and A.I. Faden. 1978. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 275:450.
23. Soulioti A.M.A. 1988. Naloxone for septic shock. Lancet ii:1133.
24. Ventura S. and J. Ludbrook. 1995. L-arginine reverses the abolition of hypovolemic decompensation by N-nitro-L-arginine methyl ester and naloxone in conscious rabbits. Eur. J. Pharmacol. 294:369.
25. Benoît Boe U., F. Gauvin, A.M. Guerguerian, C.A. Farrell, J. Lacroix and M. Jenicek. 1998. Therapy of shock with naloxone: A meta-analysis. Crit. Care Med. 26:1910.
26. Boscolo P. and M. Carmignani. 1986. Mechanisms of cardiovascular regulation in male rabbits chronically exposed to cadmium. Br. J. Ind. Med. 43:605.
27. Bolognini S., M. Cagossi, R. Sacco, G. Elia and F. Zucchetti. 1982. Hemodynamic, metabolic and histological findings during canine superior mesenteric artery hypoperfusion. Ital. J. Surg. Sci. 12:93.
28. Carmignani M., V.N. Finelli and P. Boscolo. 1983. Mechanisms in cardiovascular regulation following chronic exposure of male rats to inorganic mercury. Toxicol. Appl. Pharmacol. 69:442.
29. Carmignani M., A.R. Volpe, P. Boscolo, N. Qiao, M. Di Gioacchino, A. Grilli and M. Felaco. 2000. Catecholamine and nitric oxide systems as targets of chronic low-level lead exposure in inducing selective functional impairment. Life Sci. 68:401.
30. Currò D., A.R. Volpe and P. Preziosi. 1996. Nitric oxide synthase activity and non-adrenergic non-cholinergic relaxation in the rat gastric fundus. Br. J. Pharmacol. 117:717.
31. Desiderio D.M., F.S. Tanzer and G. Fridland. 1985. Metabolic profiling of opioid peptides in tooth pulp by HPLC and radioreceptor assay. Neuropeptides 6:463.
32. Reisine T. and G. Pasternak. 1996. Opioid analgesics and antagonists. In Goodman & Gilman's the Pharmacological Basis of Therapeutics. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon and A. Goodman Gilman, ed. McGraw-Hill New York, p. 521.
33. Salerno L., V. Sorrenti, C. Di Giacomo, G. Romeo and M.A. Siracusa. 2002. Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr. Pharm. Design 8:215.
34. Moore F.A. 1999. The role of the gastrointestinal tract in postinjury multiple organ failure. Am. J. Surg. 178:449.
35. Gardiner S.M., P.A. Kemp, J.E. March and T. Bennet. 1995. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol. 116:2005.
36. Dugas M.A., F. Proulx, A. de Jaeger, J. Lacroix and M. Lambert. 2000. Markers of tissue hypoperfusion in pediatric septic shock. Intensive Care Med. 26:75.
37. Suffredini A.F. 1998. Myocardial dysfunction in sepsis: clinical and experimental investigations. Schweiz Med. Wochenschr. 128:1444.
38. Court O., A. Kumar, J.E. Parrillo and A. Kumar. 2002. Clinical review: Myocardial depression in sepsis and septic shock. Crit. Care 6:500.
39. Shulz R., D.L. Panas, R. Catena, S. Moncada, P.M. Olley and G.D. Lopaschuk. 1995. The role of nitric oxide in cardiac depression induced by interleukin-1-beta and tumour necrosis factor-alpha. Br. J. Pharmacol. 114: 27.
40. Isobe H., K. Okajima, M. Uchiba, N. Harada and H. Okabe. 2002. Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of NO synthase in rats. Blood 99:1638.
41. Mungrue I.N., R. Gros, X. You, A. Pirani, A. Azad, T. Csont, R. Schulz, J. Butany and D.J. Stewart. 2002. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest. 109:735.
42. Mitaka C., Y. Hirata, K. Yokoyama, H. Wakimoto, M. Hirokawa, T. Nosaka and T. Imai. 2003. Relationships of circulating nitrite/nitrate levels to severity and multiple organ dysfunction syndrome in systemic inflammatory response syndrome. Shock 19:305.
43. Toung T., P.M. Reilly, K.C. Fuh, R. Ferris and G.B. Bulkley. 2000. Mesenteric vasoconstriction in response to hemorrhagic shock. Shock 13:267.
44. Curtis M.T. and A.M. Lefer. 1981. Beneficial action of naloxone in splanchnic artery occlusion shock. Experientia 37:403.
45. Zingarelli B., G.S. Scott, P. Hake, A.L. Salzman and C. Szabo. 2000. Effects of nicaraven on nitric oxide-related pathways and in shock and inflammation. Shock 13:126.
46. Avontuur J.A.M., F. Boomsma, A.H. van den Meiracker, F.H. de Jong and HA. Bruining. 1999. Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock. Circulation 99:271.
47. Fujita H., J. Tomiyama, H. Kudo, I. Morita and S. Murota. 2000. Sera from patients with sepsis induce nitric oxide production in vascular smooth muscle cells. Mediat. Inflamm. 9:285.
48. Suzuki N., A. Sakamoto and R. Ogawa. 2002. Effect of L-canavanine, an inhibitor of iNOS, on myocardial dysfunction during septic shock. J. Nippon Med. Sch. 69:13.
49. Boveris A., S. Alvarez and A. Navarro. 2002. The role of mitochondrial nitric oxide synthase in inflammation and septic shock. Free Radic. Biol. Med. 33:1186.
50. Collins J.L., Y. Vodovotz, C. Hierholzer, et al. 2003. Characterization of the expression of inducible nitric oxide synthase in rat and human liver during hemorrhagic shock. Shock 19:117.
51. McDonald M.C., M. Izumi, S. Cuzzocrea and C. Thiemermann. 2002. A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock. J. Physiol. Pharmacol. 5:555.
52. Ceppa E.P., K.C. Fuh and G.B. Bulkley. 2003. Mesenteric hemodynamic response to circulatory shock. Curr. Opin. Crit. Care 9:127.
53. Summers R.L., Z. Li and D. Hildebrandt. 2003. Effect of a delta receptor agonist on duration of survival during hemorrhagic shock. Acad. Emerg. Med. 10:587.
54. Conti P., M. Reale, R.C. Barbacane, R. Letourneau and T.C. Theoharides. 1998. Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell-deficient W/WV mice. FASEB J. 12:1693.
55. Bakker J., R. Groyer, A. McLuckie, et al. 2004. Glaxo Wellcome International Septic Shock Study Group. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-control led multicenter study (study no. 144-002). Crit. Care Med. 32:1.
56. Levy B., C. Vallee, F. Lauzier, et al. 2004. Comparative effects of vasopressin, norepinephrine and L-Canavanine, a selective inhibitor of inducible nitric oxide synthase in endotoxic shock. Am. J. Physiol. Heart Circ. Physiol. 287:H209.
57. Acharya A. and V. Tripathi. 2003. Novel peptides enhance the production of nitric oxide and inducible nitric oxide synthase (iNOS) gene expression in murine macrophage. Int. J. Immunopathol. Pharmacol. 16:241
58. Kempuraj D., S. Frydas, P. Conti, K Kandere, W. Boucher, R Letourneau, B. Madhappan, S.H. Huang, S. Koreaki, S. Christodonlou and T.C. Theoharides. 2003. Interleukin-25: a new IL-17 family member with growth factor/inflammatory action. Int J. Immunopathol. Pharmacol. 16:185
59. Kempuraj D., S. Frydas, K Kandere, B. Madhappan, R Letourneau, S. Christodoulou, W. Boncher, G. Riccioni, P. Conti and T. C. Theoharides. 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16:95.
60. Yang E., A.S. Comtois, L. Fang, N.G. Hartman and G. Blaise. 2002. Nitric oxide-derived nitrate anion contributes to endotoxic shock and multiple organ injury/dysfunction. Crit. Care Med. 30:650.